R Blankart
Papers
1
Total Citations
40
H-Index
1
About
R. Blankart is a leading health economist and health policy researcher whose work focuses on the evaluation of medical technologies and the use of real-world evidence (RWE) in health technology assessment (HTA). Their major contributions lie in critically appraising the suitability of real-world data (RWD) sources for generating evidence that supports regulatory and reimbursement decisions, particularly for medical devices in Europe. A key study, “Do existing real-world data sources generate suitable evidence for the HTA of medical devices in Europe? Mapping and critical appraisal” (2021, 40 citations), systematically evaluates the gaps and opportunities in leveraging RWD for HTA, providing a foundational framework for improving evidence generation in this domain. Blankart’s work is highly influential in shaping how policymakers and researchers assess the value of medical innovations, bridging the gap between data availability and decision-making. Their research has significant implications for the efficiency and effectiveness of healthcare systems, ensuring that technological advancements translate into tangible patient benefits.
Research Focus
Key Achievements
Top Papers
- 1